Patients & Caregivers
If you or someone you know has been diagnosed with ovarian cancer, or
are at a high-risk for
ovarian cancer, the
right treatment path
can lead to more
positive results.
Healthcare Professionals
Approximately 1 in 5 women
will develop a pelvic mass
in their lifetime.2,12 Learn
more about CA125 + HE4,
a new differential
diagnostic that can
help determine the
most appropriate
course of care.
CA125 + HE4 =
RISK STRATIFICATION
The path to more optimal patient outcomes begins
with the new CA125 + HE4 stratification tool.
The CA125 + HE4 test combination from Fujirebio Diagnostics, Inc., helps
connect ovarian cancer patients with the right doctor for the most optimal
outcome. Explore more about ovarian cancer, the new CA125 + HE4 test, and
how this test will help the steer patients down the right treatment path.
CA125 + HE4 RISK STRATIFICATION TOOLS
Calculate Risk of Ovarian Malignancy Algorithm (ROMA) with:
